Funds holding CNS PHARMACEUTICALS INC
2 funds declare a position · 0 ETFs and 2 other funds · 21.5K $ · US18978H5081
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 6,366 | 19.8K $ | as of Feb 28, 2026 · Original filing | |
| 2 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 555 | 1.7K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
11 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Stonepine Capital Management, LLC | 61,000 | 145.8K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 45,830 | 110K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 23,189 | 55.7K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,524 | 32.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,310 | 3.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 729 | 1.7K $ | as of Mar 31, 2026 |
| BARRETT & COMPANY, INC. | 8 | 19 $ | as of Mar 31, 2026 |
| MAI Capital Management | 3 | 8 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 1 | 2 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | 2 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 2 $ | as of Mar 31, 2026 |